• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管胃结合部腺癌应归类为食管癌吗?根据第七版 AJCC TNM 分类的比较分析。

Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification.

机构信息

Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Ann Surg. 2012 May;255(5):908-15. doi: 10.1097/SLA.0b013e31824beb95.

DOI:10.1097/SLA.0b013e31824beb95
PMID:22504190
Abstract

OBJECTIVE

The aim of this study was to evaluate the adequacy of esophageal classification for adenocarcinoma of the esophagogastric junction (AEJ) of the seventh American Joint Committee on Cancer (AJCC) TNM classification.

BACKGROUND

The seventh AJCC TNM classification proposed the new classification for AEJ as a part of esophageal cancer depending on the esophagogastric junction (EGJ) involvement. However, there are still many controversies over the classification system for AEJ.

METHODS

A review of pathologic reports and photographic findings at Seoul National University Hospital from 2003 to 2009 identified 4524 patients with single, primary adenocarcinoma of the EGJ (n = 497) and other regions of the stomach (GC, n = 4027) who underwent an operation with curative intent. We analyzed the clinicopathologic features and postoperative prognosis of AEJ using the Siewert classification and the seventh AJCC TNM classification.

RESULTS

There was no Siewert type I (AEJ I) in this study. The prognosis of AEJ was similar to that of GC. There was no difference in clinicopathologic features between AEJ II and AEJ III. Even though AEJ extending into the EGJ (AEJe) showed more advanced pathologic features than AEJ not extending into the EGJ (AEJg), the prognosis of AEJe and AEJg was not significantly different when stratified by T stage. Compared with the classification of gastric cancer applied for AEJ, esophageal classification for AEJ from the seventh AJCC TNM classification showed a loss of distinctiveness at each TNM stage.

CONCLUSIONS

To evaluate the postoperative prognosis of AEJ within the stomach, AEJ II and AEJ III should be considered a part of gastric cancer irrespective of EGJ involvement.

摘要

目的

本研究旨在评估第七版美国癌症联合委员会(AJCC)TNM 分期中食管腺癌(AEJ)的食管分类对 AJCC 分期的充分性。

背景

第七版 AJCC TNM 分期将 AEJ 作为食管癌的一部分提出,取决于食管胃结合部(EGJ)的受累情况。然而,AEJ 的分类系统仍存在许多争议。

方法

对 2003 年至 2009 年在首尔国立大学医院进行的手术治疗且具有单一原发性 EGJ 腺癌(n = 497)和胃其他部位腺癌(GC,n = 4027)的病理报告和摄影结果进行回顾性分析。我们使用 Siewert 分类和第七版 AJCC TNM 分类分析 AEJ 的临床病理特征和术后预后。

结果

本研究中没有 Siewert Ⅰ型(AEJ I)。AEJ 的预后与 GC 相似。AEJ II 型和 AEJ III 型的临床病理特征无差异。即使延伸至 EGJ 的 AEJ(AEJe)具有比未延伸至 EGJ 的 AEJ(AEJg)更先进的病理特征,但根据 T 分期分层时,AEJe 和 AEJg 的预后无显著差异。与用于 AEJ 的胃癌分类相比,第七版 AJCC TNM 分类的 AEJ 食管分类在每个 TNM 分期的区分度都有所降低。

结论

为了评估 AEJ 在胃内的术后预后,无论 EGJ 是否受累,AEJ II 型和 AEJ III 型均应被视为胃癌的一部分。

相似文献

1
Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification.食管胃结合部腺癌应归类为食管癌吗?根据第七版 AJCC TNM 分类的比较分析。
Ann Surg. 2012 May;255(5):908-15. doi: 10.1097/SLA.0b013e31824beb95.
2
Comparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinoma.比较食管第七版 AJCC/TNM 与 14 版 JCGC 分期系统在 Siewert Ⅱ型腺癌中的预后一致性。
Anticancer Res. 2013 Aug;33(8):3461-5.
3
[Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].[UICC-AJCC第7版食管癌和胃癌TNM分期系统对食管胃交界腺癌(SiewertⅡ型)预后预测价值的评估]
Zhonghua Zhong Liu Za Zhi. 2014 Dec 23;36(12):916-21. doi: 10.3760/cma.j.issn.0253-3766.2014.12.008.
4
Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.根据 AJCC 第 8 版,比较胃和食管分类系统在食管胃结合部腺癌中的应用:来自中国两家大容量机构的回顾性观察研究。
Gastric Cancer. 2019 May;22(3):506-517. doi: 10.1007/s10120-018-0890-2. Epub 2018 Nov 2.
5
[CT in differentiation of cT3 and cT4a Siewert type II esophagogastric junction adenocarcinoma: A comparison study based on UICC/AJCC 8th edition and IGCA 4th edition].[CT在鉴别cT3和cT4a期Siewert II型食管胃交界腺癌中的应用:基于UICC/AJCC第8版和IGCA第4版的比较研究]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):1013-1018.
6
[Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].[不同TNM分期系统在食管胃交界部Siewert III型腺癌中的优势比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):143-148.
7
Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.在国际抗癌联盟(UICC)第7版TNM分期中,食管及胃食管交界腺癌的包膜外淋巴结受累能否作为精确划分pN1的一个指标?†
Eur J Cardiothorac Surg. 2014 Jun;45(6):1001-10. doi: 10.1093/ejcts/ezt546. Epub 2014 Jan 28.
8
Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.胃食管结合部腺癌分期:AJCC 第 6 版胃和第 7 版食管分期系统与第 7 版的比较。
Ann Surg Oncol. 2013 Aug;20(8):2713-20. doi: 10.1245/s10434-013-2898-5. Epub 2013 Mar 2.
9
Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us?西沃特Ⅲ型食管胃交界腺癌:第8版TNM分期能帮到我们吗?
Updates Surg. 2018 Jun;70(2):241-249. doi: 10.1007/s13304-018-0537-1. Epub 2018 May 28.
10
The 8th edition of the AJCC-TNM classification: New contributions to the staging of esophagogastric junction cancer.美国癌症联合委员会(AJCC)-肿瘤淋巴结转移(TNM)分类第8版:对食管胃交界部癌分期的新贡献
Cir Esp (Engl Ed). 2019 Oct;97(8):432-437. doi: 10.1016/j.ciresp.2019.03.006. Epub 2019 Apr 24.

引用本文的文献

1
Korea, Japan, Europe, and the United States: Why are guidelines for gastric cancer different?韩国、日本、欧洲和美国:为何胃癌指南存在差异?
Gastric Cancer. 2025 Apr 16. doi: 10.1007/s10120-025-01613-x.
2
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).《2024年韩国胃癌诊疗指南:基于证据的多学科方法(2022年指南更新)》
J Gastric Cancer. 2025 Jan;25(1):5-114. doi: 10.5230/jgc.2025.25.e11.
3
Exploring Dietary Factors and Esophageal Adenocarcinoma: Insights From Mendelian Randomization Study.
探索饮食因素与食管腺癌:孟德尔随机化研究的见解
Food Sci Nutr. 2024 Oct 18;12(11):9600-9606. doi: 10.1002/fsn3.4527. eCollection 2024 Nov.
4
Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia.贲门或贲门下腺癌患者食管胃交界侵犯的预后意义
Cancers (Basel). 2023 Mar 8;15(6):1656. doi: 10.3390/cancers15061656.
5
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.《2022年韩国胃癌诊疗指南:基于证据的多学科方法》
J Gastric Cancer. 2023 Jan;23(1):3-106. doi: 10.5230/jgc.2023.23.e11.
6
SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma.SIRGs 评分可能是预测食管胃结合部腺癌预后和免疫治疗反应的指标。
Front Immunol. 2022 Aug 16;13:977894. doi: 10.3389/fimmu.2022.977894. eCollection 2022.
7
The probability of Lymph node metastasis with a tumor size larger than and smaller than 4 cm is different in stages T1-T3 of Siewert type II adenocarcinoma of esophagogastric junction: A Population-Based Study.胃食管交界部Siewert II型腺癌T1-T3期肿瘤大小大于和小于4 cm时的淋巴结转移概率不同:一项基于人群的研究
J Cancer. 2021 Sep 27;12(22):6873-6882. doi: 10.7150/jca.63392. eCollection 2021.
8
Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation.通过 DNA 甲基化预测食管胃结合部腺癌的组织起源。
Gastric Cancer. 2022 Mar;25(2):336-345. doi: 10.1007/s10120-021-01252-y. Epub 2021 Sep 23.
9
Prognostic value of different lymph node staging methods for node-positive cardia gastric cancer: a register-based retrospective cohort study.不同淋巴结分期方法对阳性贲门胃癌预后价值的回顾性队列研究:基于登记的研究。
BMJ Open. 2021 Aug 23;11(8):e050378. doi: 10.1136/bmjopen-2021-050378.
10
Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis.新辅助放化疗对比新辅助化疗可改善局部进展期胃食管结合部腺癌患者的生存:一项倾向评分匹配分析。
BMC Surg. 2021 Mar 17;21(1):137. doi: 10.1186/s12893-021-01136-z.